<--- Back to Details
First PageDocument Content
Health / Health Canada / Pharmacy / Therapeutic Products Directorate / Drug Identification Number / Generic drug / Pharmaceutical industry / Formulary / Health Products and Food Branch / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy
Date: 2013-06-24 11:49:29
Health
Health Canada
Pharmacy
Therapeutic Products Directorate
Drug Identification Number
Generic drug
Pharmaceutical industry
Formulary
Health Products and Food Branch
Pharmaceutical sciences
Pharmacology
Pharmaceuticals policy

Minutes of meeting - June 27, 2011, Canadian Generic Pharmaceutical Association (CGPA)

Add to Reading List

Source URL: hc-sc.gc.ca

Download Document from Source Website

File Size: 34,97 KB

Share Document on Facebook

Similar Documents

Country of Origin as a Modifier of the effect of Generation and Length of Residence on the Mental Health Outcomes of Immigrants to Canada by  Shirin Montazer

Country of Origin as a Modifier of the effect of Generation and Length of Residence on the Mental Health Outcomes of Immigrants to Canada by Shirin Montazer

DocID: 1xUDn - View Document

2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

DocID: 1vr6Q - View Document

Developing novel NMDA receptor positive modulators as neuroprotectants Yu Tian Wang Djavad Mowafaghian Centre for Brain Health and Department of Medicine/Neurology, University of British Columbia, Vancouver, Canada  The

Developing novel NMDA receptor positive modulators as neuroprotectants Yu Tian Wang Djavad Mowafaghian Centre for Brain Health and Department of Medicine/Neurology, University of British Columbia, Vancouver, Canada The

DocID: 1vnMG - View Document

Occupational Health & Safety for Federally Regulated Workplaces The federal health and safety legislation is commonly referred to as Canada Labour Code Part II and regulations under the Code. The Canada Labour Code also

Occupational Health & Safety for Federally Regulated Workplaces The federal health and safety legislation is commonly referred to as Canada Labour Code Part II and regulations under the Code. The Canada Labour Code also

DocID: 1vn7y - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C   New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document